期刊文献+

住院分裂症患者687例一日处方分析 被引量:1

Analysis of the Daily Prescription of 687 Inpatients with Schizophrenia
下载PDF
导出
摘要 目的分析天津市安定医院精神分裂症患者药物使用情况.方法对总院及分院共687例分裂症患者日医嘱微机查询.结果 (1)在687例分裂症患者中药物使用频率依次为奋乃静、舒必利、氯氮平、氯丙嗪、维思通、奎地平,换算为氯丙嗪等效剂量后,治疗剂量为13.5~4 012 mg/d,平均(367±250)mg/d.(2)687例患者中516(75.11%)例患者使用经典抗精神病药,185例(26.92%)使用非典型抗精神病药物,432例(62.88%)为单一用药者,255例(37.11%)患者配合使用2种抗精神病药物,而3种或3种以上抗精神病药物配用为0例,总计53例(0.08%)患者合并使用抗抑郁剂,106例(15.43%)合并心境稳定剂.(3)合并心境稳定剂频率依次为锂盐46例,丙戊酸钠30例,卡马西平30例.结论目前天津市安定医院处方方式仍以典型抗精神病药物为主,考虑与患者病程较长,大部分患者仍沿用原老医嘱,且长期住院患者受医保及经济负担影响有关. Objective To analyze the drug usage of the inpatients with Schizophrenia. Methods To search the daily prescription of 687 inpatients with Schizophrenia in headquarters and branch. Results (1)The frequency of the drug usage is PPZ, sulpiride, clozapine, CPZ, risperdal, quetiapine in turn in 687 inpatients with Schizophrenia, after converting to the equivalent dosage of CPZ, the treatment dosage is 13.5-4012 mg/d, the average is (367±250) mg/d. (2) 516 (75.11%) used the typical antipsychotic drug in 687, 185 (26.92%) used the atypical antipsychotic drug; 432(62.88%) used one drug, 255(37.11%) used two kinds of drug, and none of them used three kinds of or more than three kinds of drug; 53(0.08%) combined antidepressant, 106(15.43%) combined mood stabilizers. (3) The frequency of combined mood stabilizers is 46 with Lithium Salt, 30 with sodralproate and 30 with carbamazepine in turn. Conclusions The prescription of my hospital still is typical antipsychotic drug mainly at present, concerning with long course of illness, most still follow to using the old prescription and the long-term hospitalization patient subjecting to the medicare and the economic burden.
出处 《神经疾病与精神卫生》 2005年第1期25-27,共3页 Journal of Neuroscience and Mental Health
关键词 精神分裂症 抗精神病药物 处方 用药方式 精神卫生 Schizophrenia Antipsychotic drug Prescription analysis
  • 相关文献

参考文献6

二级参考文献24

  • 1陆明康,殷美莉,周金娣,彭英芳,郭丽华,刘倩,张良栋.抗精神病药物致粒细胞缺乏症42例分析[J].中华神经科杂志,1994,27(4):252-252. 被引量:13
  • 2任忠文,谭友才,唐永福,韩新,吴永辉,江开达.临床应用精神药物品种的调查和比较[J].上海精神医学,1996,8(3):144-147. 被引量:34
  • 3刘庆福 孙强.抗精神病药物的用药情况分析[J].中国药物滥用防治杂志,1996,(1):48-49.
  • 4Chakos M, Lieberman J, Hoffman E, et al. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry, 2001, 158:518-526.
  • 5Kane JM, Marder SR, Schooler NR, et al. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. Arch Gen Psychiatry, 2001, 58:965-972.
  • 6Bhana N, Foster RH, Olney R,et al. Olanzapine: an updated review of its use in the management of schizophrenia. Drugs, 2001, 61:111-161.
  • 7Love RC, Nelson MW. Pharmacology and clinical experience with risperidone. Expert Opin Pharmacother, 2000, 1:1441-1453.
  • 8Feltus MS, Gardner DM. Second generation antipsychotics for schizophrenia. Can J Clin Pharmacol, 1999, 6:187-195.
  • 9Conley RR, Love RC, Kelly DL, et al. Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine. Am J Psychiatry, 1999, 156:863-868.
  • 10Meltzer H.Side effects of antipsychotic medications: physician's choice of medication and patient compliance[editorial]. J Clin Psychiatry, 2000, 61 Suppl 8:3-66.

共引文献132

同被引文献8

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部